Yahoo Web Search

Search results

1. • 

     Chimerix (CMRX) Loses -24.68% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

     Zacks via Yahoo Finance· 1 year ago

     Chimerix (CMRX) has become technically an oversold stock now, which implies exhaustion of the heavy...

2. • 

     Chimerix (CMRX) Earnings Expected to Grow: What to Know Ahead of Q3 Release

     Zacks via Yahoo Finance· 1 year ago

     Chimerix (CMRX) possesses the right combination of the two key ingredients for a likely earnings...

3. • 

     Chimerix, Inc. (NASDAQ:CMRX) surges 24%; individual investors who own 43% shares profited along with...

     Simply Wall St. via Yahoo Finance· 2 months ago

     Key Insights Chimerix's significant individual investors ownership suggests that the key decisions...

4. • 

     Chimerix (CMRX) Beats Q3 Earnings Estimates

     Zacks via Yahoo Finance· 1 year ago

     Chimerix (CMRX) delivered earnings and revenue surprises of 30.95% and 84.14%, respectively, for the quarter ended September 2022. Do the numbers hold...

5. • 

     With 53% ownership of the shares, Chimerix, Inc. (NASDAQ:CMRX) is heavily dominated by institutional...

     Simply Wall St. via Yahoo Finance· 1 year ago

     Every investor in Chimerix, Inc. (NASDAQ:CMRX) should be aware of the most powerful shareholder...

6. • 

     Chimerix (CMRX) Plunges on Unfavorable Pipeline Updates

     Zacks via Yahoo Finance· 2 years ago

     The development of Chimerix's (CMRX) lead candidate, ONC201, gets delayed as the FDA states that...

7. • 

     Chimerix, Inc. (NASDAQ:CMRX) Q4 2023 Earnings Call Transcript

     Insider Monkey via Yahoo Finance· 2 months ago

     Chimerix, Inc. (NASDAQ:CMRX) Q4 2023 Earnings Call Transcript February 29, 2024 Chimerix, Inc. beats...

8. • 

     Chimerix (NASDAQ:CMRX) shareholders have endured a 70% loss from investing in the stock five years...

     Simply Wall St. via Yahoo Finance· 6 months ago

     Long term investing works well, but it doesn't always work for each individual stock. It hits us in...

9. • 

     Chimerix Inc (CMRX) Reports Q3 2023 Financial Results and Operational Updates

     GuruFocus.com via Yahoo Finance· 6 months ago

     Chimerix Inc (NASDAQ:CMRX) reported a net loss of $24.0 million for Q3 2023, compared to a net...

10. • CMRX Stock Warning! Smart Biotech Investors Will Avoid Chimerix Like the Plague.

      InvestorPlace via Yahoo Finance· 8 months ago

      Chimerix (NASDAQ:CMRX), like most clinical-stage biotech stocks, is without question a high-risk play. Yet in contrast to other biotechs, where high potential rewards can outweigh this high ...